Patent details

Basic Information

Publication number:

EP3437659

PCT Application Number:

JP2017012448

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177749710

PCT Publication Number:

WO2017170434

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF A FXR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER

French Title of Invention:

COMBINAISON D'UN AGONISTE DE FXR ET D' UN ANTAGONISTE DES RÉCEPTEURS DE L' ANGIOTENSINE II

German Title of Invention:

KOMBINATION EINES FXR-AGONISTES UND EINES ANGIOTENSIN II REZEPTORANTAGONISTES

SPC Number:

Dates

Filing date:

27/03/2017

Grant date:

01/03/2023

EP Publication Date:

06/02/2019

PCT Publication Date:

05/10/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/03/2023

EP B1 Publication Date:

01/03/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/03/2023

Expiration date:

27/03/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/02/2023

 

 

Name:

Intercept Pharmaceuticals, Inc.

Address:

305 Madison Avenue, Morristown NJ 07960, United States (US)

Inventor

1

Name:

YOSHIJI, Hitoshi

Address:

Japan (JP)

2

Name:

NAMISAKI, Tadashi

Address:

Japan (JP)

Priority

Priority Number:

2016064475

Priority Date:

28/03/2016

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 45/06; A61K 31/575; A61K 31/4178; A61K 31/41; A61K 31/4184; A61K 31/42; A61K 31/4245; A61K 31/454; A61K 31/46; A61P 1/16;

Publication

European Patent Bulletin

Issue number:

202309

Publication date:

01/03/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages